274 related articles for article (PubMed ID: 20666850)
1. Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.
Murphy G
Int J Exp Pathol; 2010 Aug; 91(4):303-13. PubMed ID: 20666850
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
Georgiadis D; Yiotakis A
Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
[TBL] [Abstract][Full Text] [Related]
3. Extracellular regulation of metalloproteinases.
Yamamoto K; Murphy G; Troeberg L
Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitors of metalloproteinases.
Murphy G
Genome Biol; 2011 Nov; 12(11):233. PubMed ID: 22078297
[TBL] [Abstract][Full Text] [Related]
5. Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design.
Bertini I; Fragai M; Luchinat C
Curr Pharm Des; 2009; 15(31):3592-605. PubMed ID: 19925414
[TBL] [Abstract][Full Text] [Related]
6. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
Maskos K; Bode W
Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases: their role in arthritis and potential as therapeutic targets.
Clark IM; Parker AE
Expert Opin Ther Targets; 2003 Feb; 7(1):19-34. PubMed ID: 12556200
[TBL] [Abstract][Full Text] [Related]
9. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the function of non catalytic domains of collagenases and aggrecanases.
Nagase H; Fushimi K
Connect Tissue Res; 2008; 49(3):169-74. PubMed ID: 18661336
[TBL] [Abstract][Full Text] [Related]
11. Progress in matrix metalloproteinase research.
Murphy G; Nagase H
Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.
Pirard B; Matter H
J Med Chem; 2006 Jan; 49(1):51-69. PubMed ID: 16392792
[TBL] [Abstract][Full Text] [Related]
13. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
Miller MA; Barkal L; Jeng K; Herrlich A; Moss M; Griffith LG; Lauffenburger DA
Integr Biol (Camb); 2011 Apr; 3(4):422-38. PubMed ID: 21180771
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of matrix metalloproteinase function.
Bode W
Biochem Soc Symp; 2003; (70):1-14. PubMed ID: 14587278
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases: fold and function of their catalytic domains.
Tallant C; Marrero A; Gomis-Rüth FX
Biochim Biophys Acta; 2010 Jan; 1803(1):20-8. PubMed ID: 19374923
[TBL] [Abstract][Full Text] [Related]
18. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
Skiles JW; Gonnella NC; Jeng AY
Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against metzincin targets.
Santamaria S; de Groot R
Br J Pharmacol; 2019 Jan; 176(1):52-66. PubMed ID: 29488211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
